coenzyme Q10/Finding
One finding, on its own
A single claim from the graph, with the grade computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on withdrawal due to adverse events
PreliminaryGrade D, Preliminary. Non-human or in vitro only.FindingNull result“In safety outcomes, only the risk ratios (RR) of pharyngitis (RR 1.04, 95% CI 0.18 to 5.89) and diarrhea (RR 1.39, 95% CI 0.62 to 3.16) are mild elevated between coenzyme Q10 therapy and placebo and there were no differences in the number of withdrawals due to adverse effects (RR 0.61, 95% CI 0.23 to 1.62).”
Quoted verbatim from Coenzyme Q10 for Parkinson's disease.. - Study
- meta-analysis
- Dose
- 1200 mg/d for 16 months
- Population
- patients with early and midstage Parkinson's disease; Cochrane meta-analysis of 4 RCTs, 452 patients, coenzyme Q10 versus placebo
Effect 0.61 risk ratio, 95% CI 0.23 to 1.62
Coenzyme Q10 for Parkinson's disease.2011PMID:22161420Permalink
Keep reading
- Everything the graph holds on coenzyme Q10
- Every compound studied against Withdrawal due to adverse events
- How to read the grade and the marks
To cite this finding: https://catalystproject.ai/e/01M38RFSM3H9K69VMW49MXCEXY